Geode Capital Management, LLC Adma Biologics, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 5,913,121 shares of ADMA stock, worth $99.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,913,121

Previous 5,667,812 4.33%

Holding current value

$99.1 Million

Previous $112 Million 4.24%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$17.6 - $24.51 $4.32 Million - $6.01 Million	245,309 Added 4.33%	5,913,121 $108 Million
Q1 2025 May 13, 2025	BUY	$15.44 - $20.61 $3.64 Million - $4.85 Million	235,428 Added 4.33%	5,667,812 $112 Million
Q4 2024 Feb 12, 2025	BUY	$15.62 - $22.62 $787,232 - $1.14 Million	50,399 Added 0.94%	5,432,384 $93.2 Million
Q3 2024 Nov 12, 2024	BUY	$11.21 - $20.03 $1.55 Million - $2.76 Million	137,989 Added 2.63%	5,381,985 $108 Million
Q2 2024 Aug 09, 2024	BUY	$5.98 - $11.18 $2.62 Million - $4.9 Million	437,890 Added 9.11%	5,243,996 $58.6 Million
Q1 2024 May 13, 2024	BUY	$4.4 - $6.74 $695,943 - $1.07 Million	158,169 Added 3.4%	4,806,106 $31.7 Million
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $912,677 - $1.34 Million	296,324 Added 6.81%	4,647,937 $21 Million
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $619,905 - $823,562	178,647 Added 4.28%	4,351,613 $15.6 Million
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $395,353 - $534,741	126,716 Added 3.13%	4,172,966 $15.4 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $1.98 Million - $2.55 Million	659,398 Added 19.47%	4,046,250 $13.4 Million
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $248,785 - $390,805	100,723 Added 3.07%	3,386,852 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $190,822 - $268,842	94,001 Added 2.94%	3,286,129 $7.99 Million
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $2.11 Million - $3.24 Million	1,474,049 Added 85.8%	3,192,128 $6.32 Million
Q1 2022 May 13, 2022	BUY	$1.28 - $1.83 $389,829 - $557,333	304,554 Added 21.55%	1,718,079 $3.14 Million
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.66 $109,469 - $166,715	100,431 Added 7.65%	1,413,525 $1.99 Million
Q3 2021 Nov 12, 2021	BUY	$1.13 - $1.65 $293,536 - $428,615	259,767 Added 24.66%	1,313,094 $1.48 Million
Q2 2021 Aug 13, 2021	SELL	$1.51 - $2.07 $460,281 - $630,981	-304,822 Reduced 22.44%	1,053,327 $1.69 Million
Q1 2021 May 12, 2021	BUY	$1.67 - $2.95 $583,518 - $1.03 Million	349,412 Added 34.64%	1,358,149 $2.39 Million
Q4 2020 Feb 12, 2021	BUY	$1.8 - $2.56 $53,265 - $75,755	29,592 Added 3.02%	1,008,737 $1.97 Million
Q3 2020 Nov 13, 2020	SELL	$2.04 - $3.74 $224,094 - $410,839	-109,850 Reduced 10.09%	979,145 $2.34 Million
Q2 2020 Aug 13, 2020	SELL	$2.42 - $3.29 $108,873 - $148,013	-44,989 Reduced 3.97%	1,088,995 $3.19 Million
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $626,064 - $1.92 Million	417,376 Added 58.24%	1,133,984 $3.27 Million
Q4 2019 Feb 13, 2020	BUY	$3.89 - $5.15 $366,103 - $484,687	94,114 Added 15.12%	716,608 $2.87 Million
Q3 2019 Nov 12, 2019	BUY	$3.19 - $5.39 $589,939 - $996,794	184,934 Added 42.26%	622,494 $2.77 Million
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $406,127 - $604,575	115,377 Added 35.81%	437,560 $1.69 Million
Q1 2019 May 14, 2019	BUY	$2.61 - $4.35 $118,110 - $196,850	45,253 Added 16.34%	322,183 $1.22 Million
Q4 2018 Feb 13, 2019	BUY	$2.17 - $6.12 $75,555 - $213,086	34,818 Added 14.38%	276,930 $661,000
Q3 2018 Nov 13, 2018	BUY	$4.39 - $6.85 $179,998 - $280,863	41,002 Added 20.39%	242,112 $1.5 Million
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $391,192 - $484,758	89,110 Added 79.56%	201,110 $907,000
Q4 2017 Feb 13, 2018	BUY	$2.06 - $3.24 $186,376 - $293,135	90,474 Added 420.3%	112,000 $359,000
Q2 2017 Aug 14, 2017	BUY	N/A	21,526	21,526 $82,000

Others Institutions Holding ADMA

# of Institutions

407

Shares Held

193M

Call Options Held

2.13M

Put Options Held

1.59M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.29B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Adma Biologics, Inc. Transaction History